US Stock MarketDetailed Quotes

ESPR Esperion Therapeutics

Watchlist
  • 1.960
  • -0.010-0.51%
Close Aug 16 16:00 ET
  • 1.980
  • +0.020+1.02%
Post 18:58 ET
384.60MMarket Cap-2305P/E (TTM)

Esperion Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Esperion Therapeutics Q2 2024 Earnings Date

Currency：USDAug 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
47.50M
73.83M
+26.33M
Beat Est.
+84.21%
+186.33%
+55.44%
EPS
-0.18
-0.33
-0.15
Miss Est.
+61.93%
+28.26%
-88.46%
Analyst Rating
Buy

Aug 17, 2024

Esperion Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 80.609M--
--2024/Q3-- / 53.166M--
Aug 12, 20242024/Q273.834M / 47.500M--
May 7, 20242024/Q1137.735M / 83.888M--
Feb 27, 20242023/Q432.250M / 28.701M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 80.609M--
--2024/Q3-- / 53.166M--
Aug 12, 20242024/Q273.834M / 47.500M--
May 7, 20242024/Q1137.735M / 83.888M--
Feb 27, 20242023/Q432.250M / 28.701M--

Unlock Free Earnings Estimates

Esperion Therapeutics Earnings Reports

  • Esperion Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 16:12 ET

  • Esperion Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 08:54 ET

  • Esperion Therapeutics | 10-K: FY2023 Annual Report

    Feb 27 09:21 ET

  • Esperion Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 08:52 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 17, 2024

    Buy

    • Buy

      75.00%

    • Hold

      0.00%

    • Sell

      25.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg